Apyx Medical Co. (NASDAQ:APYX - Get Free Report)'s share price shot up 1.4% during mid-day trading on Tuesday . The stock traded as high as $1.44 and last traded at $1.44. 30,903 shares changed hands during mid-day trading, a decline of 18% from the average session volume of 37,894 shares. The stock had previously closed at $1.42.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on APYX. BTIG Research initiated coverage on shares of Apyx Medical in a research note on Thursday, October 17th. They issued a "neutral" rating on the stock. Craig Hallum raised Apyx Medical to a "strong-buy" rating in a research report on Thursday, October 24th.
View Our Latest Stock Report on APYX
Apyx Medical Price Performance
The firm has a 50-day moving average of $1.58 and a 200 day moving average of $1.36. The company has a debt-to-equity ratio of 3.03, a current ratio of 5.46 and a quick ratio of 4.52. The company has a market capitalization of $54.20 million, a PE ratio of -1.73 and a beta of 1.26.
Apyx Medical (NASDAQ:APYX - Get Free Report) last announced its quarterly earnings results on Friday, November 8th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.15) by $0.01. The firm had revenue of $11.49 million for the quarter, compared to the consensus estimate of $11.66 million. Apyx Medical had a negative net margin of 58.59% and a negative return on equity of 137.98%. During the same quarter last year, the firm posted ($0.13) EPS. As a group, research analysts anticipate that Apyx Medical Co. will post -0.68 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Apyx Medical
A number of large investors have recently made changes to their positions in APYX. Private Advisor Group LLC raised its holdings in shares of Apyx Medical by 3.9% in the third quarter. Private Advisor Group LLC now owns 322,321 shares of the company's stock worth $400,000 after buying an additional 12,180 shares during the period. Royce & Associates LP boosted its position in Apyx Medical by 3.4% during the 3rd quarter. Royce & Associates LP now owns 2,582,490 shares of the company's stock valued at $3,202,000 after acquiring an additional 85,267 shares in the last quarter. Finally, Kingsview Wealth Management LLC grew its stake in Apyx Medical by 8.7% in the fourth quarter. Kingsview Wealth Management LLC now owns 135,245 shares of the company's stock valued at $214,000 after purchasing an additional 10,800 shares during the last quarter. 55.33% of the stock is owned by hedge funds and other institutional investors.
About Apyx Medical
(
Get Free Report)
Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.
Featured Articles
Before you consider Apyx Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Apyx Medical wasn't on the list.
While Apyx Medical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
